Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-07

Clinical Trial Update: Buspirone as a Candidate Medication for Methamphetamine Abuse [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating buspirone as a candidate for methamphetamine dependence/abuse.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buspirone (buspirone)

Snippet

Sponsor: University of Kentucky | Conditions: Methamphetamine Dependence, Methamphetamine Abuse | Phase 1 | Status: COMPLETED | Results posted: 2018-02-07